Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: RNA sequencing from patient-derived glioblastoma stem cells lines with p65 knockdown

PROVIDER: PRJNA1008062 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25723525.fastq.gz	Fastqsanger.gz
	SRR25723526.fastq.gz	Fastqsanger.gz
	SRR25723527.fastq.gz	Fastqsanger.gz
	SRR25723528.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Project description:RNA sequencing from two patient-derived glioblastoma stem cells lines with NUP98 knockdown

| PRJNA1007877 | ENA

Project description:ATAC sequencing from glioblastoma stem cells lines with NUP98 and p65 knockdown

| PRJNA1023584 | ENA

Norrie Disease Protein (NDP) gene knockdown patient-derived glioblastoma stem cell lines

Project description:Norrie Disease Protein (NDP) gene knockdown patient-derived glioblastoma stem cell lines

| PRJNA526891 | ENA

b558b858-0d4d-4a8d-b118-d1200dd7c693 - samples

Project description:Glioblastoma patient derived Fast/Slow cycling cancer stem cell RNA sequencing. Consists of 3 patient cell lines and 6 files

| EGAD00001004380 | EGA

Quiescent human glioblastoma cancer stem cells mediate tumor initiation, expansion, and recurrence following chemotherapy

Project description:We performed single cell RNA sequencing with eight patient derived xenograft samples to identify quiescent cancer stem cells in glioblastoma. Additionally two samples treated with temozolomide was sequenced to examine the evolution of the cancer stem cells upon chemotherapeutics.

2021-12-05 | GSE190129 | GEO

Project description:Characterization of patient-derived glioblastoma cell lines

| PRJNA1327912 | ENA

Human PUS7 in tRNA pseudouridylation

Project description:Pseudouridine is the first discovered and the most frequent modification in RNA. However, its biological functions in physiology and human diseases are largely unknown. Here, we show that pseudouridine synthase PUS7 is differentially expressed in glioblastoma patient tissues verse non-tumor brain tissues, and highly expressed in patient brain-derived cancer stem cells, compared to normal brain-derived neural stem cells. Upregulated expression of PUS7 predicts worse survival in glioblastoma patients in multiple databases. Indeed, we show that PUS7 plays an important role in regulating the self-renewal and tumorigenesis of glioblastoma stem cells. Overexpression of the wild type but not the catalytically inactive PUS7 increases the growth and self-renewal of GSCs. In contrast, knockdown of PUS7 dramatically suppresses GSC growth, self-renewal and tumorigenesis. Mechanistically, knockdown of PUS7 activates interferon pathway through translational control of TYK2 via PUS7-regulated tRNAs. Moreover, we have identified chemical inhibitors for PUS7 in this study. These chemical compounds target pseudouridine modification and suppress GSC growth and tumorigenesis, providing a potential therapeutic tool for GBM treatment.

2021-06-18 | GSE147342 | GEO

Identification of novel BMP target genes in glioblastoma

Project description:It has been previously described that in glioblastoma (GBM), BMPs deplete the tumorigenic potential of glioblastoma stem cells (GSCs), promoting their differentiation towards the astrocytic lineage. To gain more insight on how BMPs regulate differentiation in GSCs, we are interested in identifying new BMP target genes in GBM cells. To this end, the patient derived glioblastoma cell lines U3031MG and U3034MG were stimulated or not with 30ng/ml BMP7 for 2 and 24 h, total RNA was isolated from three biological replicates per condition, and a microarray screen with the Affymetrix U133plus2 platform was performed.

2021-05-01 | E-MTAB-9811 | biostudies-arrayexpress

A human iPSC-based neural spheroid platform for modeling glioblastoma infiltration using high-content imaging

Project description:Glioblastoma is the most aggressive adult brain tumor, characterized by resistance to therapy and high recurrence due to diffuse infiltration. To mimic glioblastoma migration, we developed a physiologically relevant co-culture model, combining patient-derived glioblastoma cell lines with cortical-like neural spheroids differentiated from human induced pluripotent stem cells. Using high-content imaging, we demonstrate that GBM1 and GBM20 cell lines migrate directionally along axons toward neural spheroids in live imaging assays and infiltrate spheroids extensively in endpoint assays, unlike non-cancerous neural stem cells. A proof-of-principle drug screen identified PF-573228 (FAK inhibitor) and Motixafortide (CXCR4 inhibitor) as potent suppressors of GBM1 and GBM20 infiltration, respectively. Bulk RNA sequencing revealed gene expression profiles correlating with invasive behavior and drug sensitivity. This platform offers a valuable model for studying glioblastoma infiltration along axons and provides proof-of-principle that migration can serve as a measurable and actionable phenotype to screen therapeutic vulnerabilities in glioblastoma.

2025-11-11 | GSE308010 | GEO

Patient-derived glioblastoma stem cells transcriptome regulation by CD109

Project description:Patient-derived glioblastoma stem cells transcriptome regulation by CD109

| PRJNA716553 | ENA